Modular program-based one-time assessment of prevalent and incident use of six generic drugs, including lapatinib, ticlopidine, telithromycin, allopurinol, diclofenac, and isoniazid. Modular programs are adaptable standardized programs. Results were generated using Modular Program 1; click here for more information. Programs were executed in December 2012.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.